Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients
- PMID: 9884835
- DOI: 10.1016/s0732-8893(98)00095-9
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients
Abstract
Little is known of the antifungal susceptibility patterns and molecular epidemiology of Cryptococcus neoformans from tropical regions. We studied 164 clinical isolates of C. neofomans from 120 Ugandan AIDS patients with cryptococcal meningitis by analyzing their electrophoretic karyotypes and antifungal susceptibility profiles. Computer-assisted analysis of karyotype patterns was performed to generate dendrograms. MICs of fluconazole and flucytosine were determined by reference methods. A total of 43 distinguishable DNA types were identified among the 164 isolates. Only 30 patients (25%) were infected with their own unique strain of c. neoformans, whereas 75% of the patients shared their infecting strain with at least one other patient. Among 17 patients with more than one CSF isolate of C. neoformans, sequential isolates were identical or highly related in 12 (71%) and were different in five patients (29%). The isolates were susceptible to both fluconazole and flucytosine and there were no instances in which a stepwise increase in either fluconazole or flucytosine MICs was observed among serial isolates. These findings suggest that the epidemiology of cryptococcal disease in AIDS patients from tropical regions may be somewhat different from that observed in more temperate climates.
PIP: Even though Cryptococcus neoformans var. neoformans is a leading cause of life-threatening mycotic infection among AIDS patients worldwide, little is known about its antifungal susceptibility patterns and molecular epidemiology in tropical regions. The authors studied 164 clinical isolates of C. neoformans from 120 Ugandan AIDS patients with cryptococcal meningitis by analyzing their electrophoretic karyotypes and antifungal susceptibility profiles. Computer-assisted analysis of karyotype patterns was performed to generate dendrograms, while the MICs of fluconazole and flucytosine were determined using reference methods. 43 distinguishable C. neoformans DNA types were identified among the 164 isolates. 30 patients (25%) were infected with their own unique strain of C. neoformans, while 75% of the patients shared their infecting strain with at least 1 other patient. Among 17 patients with more than 1 cerebrospinal fluid isolate of C. neoformans, sequential isolates were identical or highly related in 12 (71%) and were different in 5 patients (29%). The isolates were susceptible to both fluconazole and flucytosine, and there was no instance in which a stepwise increase in either fluconazole or flucytosine MICs was observed among serial isolates. These findings suggest that the epidemiology of cryptococcal disease in AIDS patients from tropical regions may be somewhat different from that observed in more temperate climates.
Similar articles
-
Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.Microbiol Spectr. 2021 Oct 31;9(2):e0072321. doi: 10.1128/Spectrum.00723-21. Epub 2021 Sep 29. Microbiol Spectr. 2021. PMID: 34585947 Free PMC article.
-
Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil.FEMS Yeast Res. 2007 Jan;7(1):152-64. doi: 10.1111/j.1567-1364.2006.00128.x. FEMS Yeast Res. 2007. PMID: 17311593
-
Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.Clin Microbiol Infect. 2013 Aug;19(8):763-9. doi: 10.1111/1469-0691.12019. Epub 2012 Oct 3. Clin Microbiol Infect. 2013. PMID: 23033854
-
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005647. doi: 10.1002/14651858.CD005647.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2018 Jul 25;7:CD005647. doi: 10.1002/14651858.CD005647.pub3 PMID: 18843697 Updated. Review.
-
A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.Mycoses. 2018 May;61(5):290-297. doi: 10.1111/myc.12747. Epub 2018 Feb 14. Mycoses. 2018. PMID: 29377368 Review.
Cited by
-
Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.J Clin Microbiol. 1998 Oct;36(10):2874-6. doi: 10.1128/JCM.36.10.2874-2876.1998. J Clin Microbiol. 1998. PMID: 9738036 Free PMC article.
-
Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis.BMC Infect Dis. 2010 Oct 4;10:289. doi: 10.1186/1471-2334-10-289. BMC Infect Dis. 2010. PMID: 20920321 Free PMC article.
-
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.J Clin Microbiol. 2003 Jan;41(1):267-72. doi: 10.1128/JCM.41.1.267-272.2003. J Clin Microbiol. 2003. PMID: 12517859 Free PMC article.
-
ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50.Front Cell Infect Microbiol. 2021 Jun 23;11:695240. doi: 10.3389/fcimb.2021.695240. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34249782 Free PMC article.
-
Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.Mycopathologia. 2012 Jun;173(5-6):427-33. doi: 10.1007/s11046-012-9528-9. Epub 2012 Feb 22. Mycopathologia. 2012. PMID: 22354778
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical